A Study of CPTX2309 in Healthy Participants
Trial Parameters
Brief Summary
The purpose of this study is to assess the safety and tolerability of CPTX2309 in healthy adult participants.
Eligibility Criteria
Inclusion Criteria: * Male and female participants who are healthy as determined by the investigator based on review of medical history, physical examination, and clinical laboratory tests obtained during the screening period. * Participant is willing and able to adhere to the study visit schedule and other protocol requirements. Exclusion Criteria: * Evidence of organ dysfunction or any clinically significant deviation from normal in physical examination, vital signs, or clinical laboratory tests beyond what is consistent with a healthy population in the region in which the study is conducted. * Use of any investigational medical device or investigational drug within 30 days or 5 half-lives of the investigational drug (whichever is longer) prior to the first administration of CPTX2309. * Note: Other protocol-defined inclusion/exclusion criteria apply